Indaptus Therapeutics, Inc. (INDP) ownership: Top institutional holder: VANGUARD GROUP INC ($140946.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 256265.00 | $140946.00 | 2025-03-31 |
| UBS Group AG | 29002.00 | $84396.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 39018.00 | $71013.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 27007.00 | $49152.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 28500.00 | $15672.00 | 2025-03-31 |
| STATE STREET CORP | 13073.00 | $7189.00 | 2025-03-31 |
| MORGAN STANLEY | 2697.00 | $4909.00 | 2026-03-31 |
| Tower Research Capital LLC (TRC) | 1890.00 | $3440.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-03-23 | |
| Sell | null | 2026-02-26 | |
| Sell | null | 2026-02-26 | |
| Sell | null | 2026-02-11 | |
| Sell | null | 2026-02-11 |
Back to INDP overview · INDP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.